Please wait a minute...

ISSN 1006-298X CN 32-1425/R

Home
About Journal
Editorial Board
Contribution
Journal
- Accepted
- Current Issue
- Archive
- Most Download
- Most Read
- Most Cited
- E-mail Alert
- RSS
Subscription
Advertising
Contact Us
中文

Journal

Current Issue Accepted Archive Adv Search Most Read Most Download Most Cited E-mail Alert RSS

WeChat

Current Issue

2026, 35 (2)

Previous Issue

Obinutuzumab in the treatment of phospholipase A2 receptor associated membranous nephropathy with very high risk: an observational study CHEN Duqun, WANG Jingjing, QIU Dandan, TU Yuanmao, ZUO Ke, CHENG Zhen, LIU Zhihong 2026, 35 (2): 101-106. DOI: 10.3969/j.issn.1006-298X.2026.02.001 Abstract( 122 ) PDF (2142KB) ( 93 )

High-altitude acclimatization combined with exercise training effectively reduces serum uric acid levels in migrant youth: a prospective study LIU Sha, SONG Jie, AN Chuanhao, TANG Xiaofeng, XU Kaijie, GESANG Cideng 2026, 35 (2): 107-112. DOI: 10.3969/j.issn.1006-298X.2026.02.002 Abstract( 40 ) PDF (4365KB) ( 46 )

Mechanisms of phenotypic discordance in monozygotic twins carrying the DDX58 p.R109C variant ZHU Yuqi, ZHANG Changming, JIN Ying, QIN Weisong, LIU Zhihong, ZHAO Yue 2026, 35 (2): 113-119. DOI: 10.3969/j.issn.1006-298X.2026.02.003 Abstract( 39 ) PDF (4555KB) ( 27 )

Dynamic uric acid changes are associated with the rate of renal function decline in patients with stage Ⅲ diabetic kidney disease GAO Ou, CHEN Yinghua, ZHAO Xin, AN Yu, LIU Fang, XIE Honglang 2026, 35 (2): 120-125. DOI: 10.3969/j.issn.1006-298X.2026.02.004 Abstract( 48 ) PDF (1172KB) ( 42 )

Clinical and genotypic features of lupus nephritis patients with KRAS mutations ZHAO Yiting, JING Xiaoman, ZHONG Qing, ZHANG Mingchao, ZHANG Changming, LIU Zhihong, ZHANG Jiahui 2026, 35 (2): 126-133. DOI: 10.3969/j.issn.1006-298X.2026.02.005 Abstract( 33 ) PDF (4432KB) ( 38 )

Skeletal muscle density combined with traditional factors to identify the risk of mitral valve calcification in dialysis patients:a multicenter retrospective cross-sectional study WU Menghuan, TAO Yuan, GAO Yuting, REN Yuxin, ZHANG Fan, ZHOU Wen, HOU Shimei, ZHENG Jing, WANG Yao, CAO Jingyuan, WANG Xiaoxu, YANG Yan, WANG Bin, YANG Min, LI Min 2026, 35 (2): 134-140. DOI: 10.3969/j.issn.1006-298X.2026.02.006 Abstract( 44 ) PDF (2313KB) ( 30 )

SINUOUS heparin-coated stent graft for the treatment of hemodialysis access outflow vein stenosis/occlusion:one-year follow-up results of multicenter clinical trial JIANG Ziyi, WANG Yufei, WANG Yuzhu, ZHAN Shen, BAO Xuedong, WAN Heng, ZHAO Yu, FU Qining 2026, 35 (2): 141-146. DOI: 10.3969/j.issn.1006-298X.2026.02.007 Abstract( 35 ) PDF (1137KB) ( 23 )

Roxadustat on cognitive function in maintenance hemodialysis patients-propensity score-matched cohort study LIU Minglin, LIU Qian, YANG Ping, WANG Jing, YAO Peng, WANG Shaoqing 2026, 35 (2): 147-152. DOI: 10.3969/j.issn.1006-298X.2026.02.008 Abstract( 41 ) PDF (961KB) ( 17 )

Focus on patient-centered vascular access planning for patients with end-stage renal Disease WEI Tao, LIANG Yaoxian 2026, 35 (2): 153-154. DOI: 10.3969/j.issn.1006-298X.2026.02.009 Abstract( 44 ) PDF (852KB) ( 27 )

Challenges and strategies for exhausted hemodialysis vascular access DAI Bing 2026, 35 (2): 155-156. DOI: 10.3969/j.issn.1006-298X.2026.02.010 Abstract( 37 ) PDF (769KB) ( 30 )

Clinical experience on planning and protection of arteriovenous fistula vascular access GE Yongchun 2026, 35 (2): 157-158. DOI: 10.3969/j.issn.1006-298X.2026.02.011 Abstract( 34 ) PDF (732KB) ( 22 )

Metabolic dysfunction⁃associated steatohepatitis:from NASH to MASH LYU Yilin, REN Guisheng 2026, 35 (2): 159-163. DOI: 10.3969/j.issn.1006-298X.2026.02.012 Abstract( 37 ) PDF (1619KB) ( 29 )

Advances on the mechanism of acute kidney injury to chronic kidney disease NA Ying, WANG Mei, GUO Yan 2026, 35 (2): 164-168. DOI: 10.3969/j.issn.1006⁃298X.2026.02.013 Abstract( 44 ) PDF (1526KB) ( 24 )

Combined drug therapy for cardiovascular⁃kidney⁃metabolic syndrome in elderly patients WANG Qiuxia, ZHANG Jiong 2026, 35 (2): 169-174. DOI: 10.3969/j.issn.1006⁃298X.2026.02.014 Abstract( 22 ) PDF (1688KB) ( 24 )

Withdrawal of immunosuppressive therapy in the treatment of lupus nephritis CAO Ling, HU Weixin 2026, 35 (2): 175-179. DOI: 10.3969/j.issn.1006⁃298X.2026.02.015 Abstract( 28 ) PDF (782KB) ( 24 )

Construction and key technical of forearm transposed arteriovenous fistula ZHANG Lichao, JING Yan 2026, 35 (2): 180-184. DOI: 10.3969/j.issn.1006⁃298X.2026.02.016 Abstract( 33 ) PDF (22768KB) ( 82 )

Research progress on the mechanisms of gut microbiota in peritoneal dialysis⁃associated peritonitis CHEN Xingling, TENG Yanbo, ZHANG Jun, GUO Tingting 2026, 35 (2): 185-189. DOI: 10.3969/j.issn.1006⁃298X.2026.02.017 Abstract( 18 ) PDF (1753KB) ( 24 )

Obinutuzumab treatment for steroid⁃resistant minimal change disease LIU Moyuan, TU Yuanmao, WANG Jingjing, LIU Zhihong, CHENG Zhen 2026, 35 (2): 190-194. DOI: 10.3969/j.issn.1006⁃298X.2026.02.018 Abstract( 36 ) PDF (1595KB) ( 21 )

A case of Takayasu arteritis with renal injury treated with adalimumab WEN Ninghua, HUANG Ling, LI Yueyue, XU Hui 2026, 35 (2): 195-199. DOI: 10.3969/j.issn.1006⁃298X.2026.02.019 Abstract( 22 ) PDF (2004KB) ( 13 )